ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 72 filers reported holding ITEOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,308,099 | -10.7% | 5,050,968 | +7.9% | 0.00% | 0.0% |
| Q2 2023 | $61,965,769 | +2.0% | 4,680,194 | +4.9% | 0.00% | 0.0% |
| Q1 2023 | $60,745,594 | -30.6% | 4,463,306 | -0.4% | 0.00% | -33.3% |
| Q4 2022 | $87,483,093 | +6.4% | 4,479,421 | +3.8% | 0.00% | 0.0% |
| Q3 2022 | $82,241,000 | +7.3% | 4,317,157 | +16.0% | 0.00% | +50.0% |
| Q2 2022 | $76,659,000 | -28.5% | 3,721,237 | +11.7% | 0.00% | -33.3% |
| Q1 2022 | $107,203,000 | +42.7% | 3,331,313 | +106.5% | 0.00% | +50.0% |
| Q4 2021 | $75,111,000 | +78.5% | 1,613,228 | +3.5% | 0.00% | +100.0% |
| Q3 2021 | $42,072,000 | +8.1% | 1,558,236 | +2.7% | 0.00% | 0.0% |
| Q2 2021 | $38,905,000 | -25.8% | 1,516,738 | -1.1% | 0.00% | -50.0% |
| Q1 2021 | $52,409,000 | +45.5% | 1,533,322 | +44.0% | 0.00% | +100.0% |
| Q4 2020 | $36,009,000 | +120.3% | 1,064,746 | +60.7% | 0.00% | 0.0% |
| Q3 2020 | $16,342,000 | – | 662,410 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
| MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
| Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
| Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
| RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
| Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
| BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
| AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
| Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
| 683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |